Labeled ligands of anti-Mullerian hormone for diagnosis of endometriosis
OwnerPietro Giulio Signorile, Alfonso Baldiinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to isolated ligands of anti-Mullerian hormone marked so as to be directly detectable by means of magnetic resonance imaging in the endometriosic lesions. In particular, such ligands can be used in a method for diagnosing in vivo endometriosis wherein said method comprises a passage of localizing and/or evaluating the entity of the endometriosic lesions in a patient.
Claims8
An in vivo method for diagnosis of endometriosis comprising localizing and/or evaluating endometriosic lesions in a patient by administration of an isolated ligand of anti-Mullerian hormone consisting of an anti-Mullerian hormone antibody or the receptor of type II of anti-Mullerian hormone (MISIIR) to said patient, said ligand being labeled to be directly detected by an imaging technique.
Dependencies are inferred from the claim text.